CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $6,669,998
- in 2 filings, $6.7M under 10b5-1 plans
Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-22 | Schneebaum Marc R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2020-03-05 | Schneebaum Marc R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2019-03-07 | Schneebaum Marc R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2018-06-11 | Schneebaum Marc R Chief Financial Officer | Exercise or conversion | +5,223 | $99.75 | $521K | 49,033 |
| 2018-06-11 | Schneebaum Marc R Chief Financial Officer | Exercise or conversion | +2,734 | $61.60 | $168K | 51,767 |
| 2018-06-11 | Schneebaum Marc R Chief Financial Officer | Sale | −10,099 | $287.46 | $2.9M | 41,668 |
| 2018-06-11 | Schneebaum Marc R Chief Financial Officer | Exercise or conversion · Stock Option | −5,223 | 1,205 | ||
| 2018-06-11 | Schneebaum Marc R Chief Financial Officer | Exercise or conversion · Stock Option | −2,734 | 1,640 | ||
| 2018-03-01 | Schneebaum Marc R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2017-03-02 | Schneebaum Marc R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +27,300 | 27,300 | ||
| 2016-07-22 | Schneebaum Marc R Chief Financial Officer | Grant or award | +24,501 | 43,809 | ||
| 2016-07-22 | Schneebaum Marc R Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +98,002 | 98,002 | ||
| 2016-07-22 | Schneebaum Marc R Chief Financial Officer | Grant or award | +22,969 | 42,277 | ||
| 2016-07-22 | Schneebaum Marc R Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +91,876 | 91,876 | ||
| 2016-07-22 | Schneebaum Marc R SVP and CFO | Grant or award | +25,714 | 27,856 | ||
| 2016-07-22 | Schneebaum Marc R SVP and CFO | Shares withheld for taxes | −8,548 | $9.48 | $81K | 19,308 |
| 2015-10-02 | Schneebaum Marc R SVP and CFO | Grant or award · Employee Stock Option (Right to Buy) | +153,100 | 153,100 | ||
| 2014-12-08 | Schneebaum Marc R SVP and CFO | Grant or award | +75,000 | 75,000 | ||
| 2014-12-08 | Schneebaum Marc R SVP and CFO | Grant or award · Employee Stock Option (Right to Buy) | +225,000 | 225,000 |
Page 1 of 1 · 19 trades